Autologous Stem Cell and Non-Stem Cell Based Therapies Market

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Companies

Companies
/ / ,

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Companies Vericel Corporation Holostem Terapie Avanzate Anterogen Co. Ltd. BrainStorm Cell Therapeutics Fibrocell Science Cytori Therapeutics TiGenix (Takeda) CORESTEM Inc. Smith & Nephew (via Osiris Therapeutics) Pluristem Therapeutics ThermoGenesis Holdings Regenexx Gilead Sciences Novartis Fate Therapeutics Medeor Therapeutics Lineage Cell Therapeutics GenCure Aastrom Biosciences (Vericel) Celgene […]

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size to Reach USD 25.78 Billion by 2034

Healthcare
/ /

The autologous stem cell and non-stem cell based therapies market is projected to expand from approximately USD 9.64 billion in 2025 to around USD 25.78 billion by 2034. This growth corresponds to a strong CAGR of 11.55%, showcasing the sector’s rapid evolution driven by technological advancements and rising demand for personalized medicine. The regenerative medicine

Scroll to Top